Zephyrnet Logo

Tag: Therapeutics

Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology

Company is targeting pancreatic cancer pain with advanced nerve detection and treatment technology New York, March 12, 2024 - (Plato Data) - Benzinga has published...

Top News

The Week’s 10 Biggest Funding Rounds: Obsidian Therapeutics And Flip Headline Another Strong Week

Want to keep track of the largest startup funding deals in 2024 with our curated list of $100 million-plus venture deals to U.S.-based companies?...

French Sales Subsidiary Eisai S.A.S. to Divest Rights for Loxapac And Parkinane LP to CNX Therapeutics

Eisai Co., Ltd. announced today that its French sales subsidiary Eisai S.A.S. entered into an agreement to transfer the rights in France, the French...

The 10 Biggest Rounds Of March: Wonder, Biotech Headline Big Month

This is a monthly feature that runs down the month’s top 10 funding rounds in the U.S. Check out the biggest rounds of last...

CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia

HONG KONG, China and WILMINGTON, Del., Apr 1, 2024 - (ACN Newswire) - China Medical System Holdings Limited (“CMS” or the “Group”) and Incyte (Nasdaq:INCY)...

Old Dogs Can Inspire New Business Models

People with puppies are tired. People with senior dogs are broke. That, in oversimplified terms, is a pretty consistent anecdotal finding among pet owners. As...

Judge Denies Injunction For Tyvaso Drug Competitor – Law360

By Jared Foretek (March 29, 2024, 9:32 PM EDT) -- A D.C. federal judge Friday denied drugmaker United Therapeutics Corp.'s attempt to preemptively...

Judge Denies Injunction For Tyvaso Drug Competitor – Law360 UK

By Jared Foretek (March 29, 2024, 9:32 PM EDT) -- A D.C. federal judge Friday denied drugmaker United Therapeutics Corp.'s attempt to preemptively...

The Week’s 10 Biggest Funding Rounds: Celestial AI Tops List Of Large Raises

Want to keep track of the largest startup funding deals in 2024 with our curated list of $100 million-plus venture deals to U.S.-based companies?...

PassPort Technologies, Inc. Announces Positive Interim Phase I Results of Zolmitriptan Transdermal Microporation System for the Treatment of Acute Migraine | BioSpace

SAN DIEGO, March 29, 2024 /PRNewswire/ -- PassPort Technologies, Inc. (PPTI), based in San Diego, a clinical-stage drug and medical device development company, today...

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update | BioSpace

Positive Business Momentum and Sales Pipeline Growth Following FDA 510(k) Clearance of Vivos’ Proprietary Oral Medical Devices to Treat Severe Obstructive Sleep Apnea Annual Operating...

3 New Studies Show How Cannabis is Helping Doctors in the Fight Against Cancer

What The New Studies On Cannabis and Cancer Say According to the World Cancer Research Fund, there were around 18 million cases of cancer globally...

Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine

mRNA-1283 induced a more robust immune response compared to Spikevax® COVID-19 vaccine, mRNA-1273.222 Next-generation mRNA vaccine design offers the potential of longer shelf life and storage...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?